![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 8, 5749-5755, February 22, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,From the Department of Molecular Biology and Functional Genomics, Stockholm University, SE-10691 Stockholm, Sweden
Received for publication, July 12, 2001, and in revised form, November 27, 2001
| |
ABSTRACT |
|---|
|
|
|---|
The active site residue Asn-437 in protein R1 of
the Escherichia coli ribonucleotide reductase makes a
hydrogen bond to the 2'-OH group of the substrate. To elucidate its
role(s) during catalysis, Asn-437 was engineered by site-directed
mutagenesis to several other side chains (Ala, Ser, Asp, Gln). All
mutant proteins were incapable of enzymatic turnover but promoted rapid protein R2 tyrosyl radical decay in the presence of the
kcat inhibitor 2'-azido-2'-deoxy-CDP with
similar decay rate constants as the wild-type R1. These results show
that all Asn-437 mutants can perform 3'-H abstraction, the first
substrate-related step in the reaction mechanism. The most interesting
observation was that three of the mutant proteins (N437A/S/D) behaved
as suicidal enzymes by catalyzing a rapid tyrosyl radical decay also in
reaction mixtures containing the natural substrate CDP. The suicidal
CDP-dependent reaction was interpreted to suggest
elimination of the substrate's protonated 2'-OH group in the form of
water, a step that has been proposed to drive the 3'-H abstraction
step. A furanone-related chromophore was formed in the N437D reaction,
which is indicative of stalling of the reaction mechanism at the
reduction step. We conclude that Asn-437 is essential for catalysis but
not for 3'-H abstraction. We propose that the suicidal N437A, N437S,
and N437D mutants can also catalyze the water elimination step, whereas the inert N437Q mutant cannot. Our results suggest that Asn-437, apart
from hydrogen bonding to the substrate, also participates in the
reduction steps of catalysis by class I ribonucleotide reductase.
The enzyme ribonucleotide reductase
(RNR)1 catalyzes the
reduction of ribonucleotides to the corresponding deoxyribonucleotides (1). RNR is crucial to all living organisms because the direct reduction is the only pathway for de novo synthesis of the
DNA precursors. Currently three major RNR classes are known (1, 2).
Despite their different subunit composition and metal and cofactor
requirements, their substrate binding domains are homologous (3), and
they are all considered to use radical chemistry involving a thiyl
radical initiating catalysis (4, 5). However, the mode of thiyl radical
formation as well as the details of the reaction mechanism differ
between the classes, and only two cysteines in the active site are
fully conserved in all classes. This study shows that an asparagine
that is conserved in the active sites of class I and II RNRs is
essential for catalysis.
The aerobic class Ia RNR of Escherichia coli is a well
characterized representative of class I RNRs and a prototype for
eukaryotic, animal viral, and some eubacterial and archean RNRs (1, 2). The E. coli enzyme consists of two homodimeric subunits,
denoted proteins R1 and R2, of known three-dimensional structures (6, 7). Protein R1 contains the substrate binding site with the catalytically essential redox-active cysteines (8), which have been
identified by means of site-directed mutagenesis (9-12). Cysteines 225 and 462 interact directly to reduce the substrate, and cysteine 439 is
proposed to transiently harbor a thiyl radical that initiates
catalysis. At position 122, the R2 protein contains a stable tyrosyl
radical essential for catalysis (13) and an adjacent dinuclear iron
site (6, 14). All class I RNRs have an array of conserved
hydrogen-bonded residues between the active site of R1 and the tyrosyl
radical of R2 (6, 7, 15). The hydrogen-bonded array has been
proposed to function as a radical transfer pathway between the Tyr-122
in R2 and the Cys-439 in R1 (1, 16, 17), which has been corroborated by
mutational analysis of the residues conserved in the pathway (9, 12, 13, 18-23).
The reaction mechanism of class I RNRs has been extensively studied
during the last two decades. Many important steps of the reaction have
been identified using isotope-labeled substrates (24, 25) and
2'-substituted substrate analogues (26-29). Scheme 1 outlines a mechanism based on
the x-ray crystal structure of an R1-substrate complex (8) and
theoretical studies (16, 30) and is an extension of the mechanism
originally proposed by Stubbe and van der Donk (31). The essentials of
the mechanism are as follows. In the initial step, a thiyl radical
(step 1 in Scheme 1) is formed on Cys-439 by radical
transfer to Tyr-122 in R2 via the proposed radical transfer path. The
thiyl radical then abstracts a hydrogen from the 3' position of the ribose forming an oxidized 3'-carbon-centered substrate radical (step 2 in Scheme 1). Water is eliminated from the
2'-position, forming a 3'-keto-radical intermediate (step 3 in Scheme 1), which is subsequently reduced by the redox-active
cysteine pair Cys-225 and Cys-462 (steps 4-5 in Scheme 1).
The hydrogen initially abstracted is then returned to the 3' position
of the substrate by Cys-439 (step 6 in Scheme 1). Finally,
the Tyr-122 radical is regenerated by radical transfer back to Cys-439. The oxidized active site cystine is then reduced by a C-terminal redox-active cysteine pair, Cys-754 and Cys-759 (9, 10), and the enzyme
is ready for another turnover.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (17K):
[in a new window]
Scheme 1.
The active site region of R1 contains a few additional conserved residues, Ser-224, Asn-437, and Glu-441 (8). Glu-441 was recently shown to be essential for catalysis and was also shown to contribute to substrate binding (32). The study corroborates the proposed function of Glu-441 acting as a base in the reaction mechanism (Scheme 1) and corroborates its proposed substrate binding function seen in the R1-substrate structure (7, 8, 16, 33). Interestingly, the suicidal mutant protein E441Q allowed trapping and identification of a disulfide anion radical intermediate (34, 35), the first demonstration of one of the postulated radical intermediates of the wild-type reaction mechanism.
Asn-437 has been suggested to participate in the reduction step (8). It is also proposed to have a structural role stabilizing the loop in the active site containing Cys-439 (36) and binding the substrate 2'-OH (8). Based on structural and theoretical studies of the substrate reaction, Asn-437 and Glu-441 have been proposed to be important in the water elimination step (8, 16, 30) (Scheme 1).
In this study, several mutants of the conserved class I residue Asn-437
were constructed and characterized to elucidate the role(s) of this
asparagine in the reaction mechanism of class I RNRs. Biochemical and
biophysical characterization of the mutant R1 proteins shows that all
mutants can perform the initial 3'-H abstraction and that Asn-437 is
essential for later steps in the reaction mechanism.
| |
EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
Materials-- Oligonucleotides used for mutagenesis were: N437S, d(5'-GCGTCAGTCTAGCCTGTGCCTGG-3'); N437D, d(5'-GCGTCAGTCTGACCTGTGCC-3'); N437A, d(5'-GCGTCAGTCTGCGCTGTGCCTGG-3'); and N437Q, d(5'-GTCAGTCTCAGCTGTGCCTGG-3'). Underlining denotes mismatched nucleotide, and boldface denotes the mutant codon. These mutagenic primers were synthesized and purified by Scandinavian Gene Synthesis AB.
Restriction enzymes used were SfuI from Roche Molecular Biochemicals and MluI from Promega. The 2'-azido-2'-deoxy-CTP from U. S. Biochemical Corp. was purchased from Amersham Biosciences, Inc. Triethylamine bicarbonate buffer was prepared by titrating 1 M triethylamine with gaseous CO2 to pH 8.0. CDP, ATP, NADPH, benzyl-DEAE-cellulose, triethylamine, and myosin were from Sigma. dTTP (100 mM, pH 7.5) was from Amersham Biosciences, Inc.. DTT was from Saveen Biotech AB. HEPES was from ICN Biomedicals Inc., and Tris-Cl was from Merck. E. coli thioredoxin and thioredoxin reductase were expressed and purified as described in Lunn et al. (37) and Russel and Model (38).
Preparation of 2'-Azido-2'-deoxy-CDP (CzDP)--
The CzDP was
obtained from its triphosphate derivative (CzTP) by incubation
with myosin to hydrolyze the
-phosphate. The CzDP was separated from
myosin using benzyl-DEAE anion exchange chromatography with a
triethylamine bicarbonate gradient (20-650 mM) at
4-8 °C (39). Fractions were pooled and freeze-dried. The remaining
triethylamine was removed by washing with methanol and evaporation for
three cycles. The CzDP was dissolved in 20 mM Tris-HCl, pH
7.6. Alternatively, the CzDP was separated from myosin by
centrifugation using a Centricon filter from Amicon with
10,000-molecular weight cut-off, freeze-dried, and dissolved in 20 mM Tris-Cl, pH 7.6.
Bacterial Strains--
E. coli CJ236
(dut-1, ung-1, thi-1,
relA1/pCJ105) and E. coli MV1190
(
(lac-proAB), thi, supE,
(srl-recA)306::Tn10/F'
traD36, proAB,
lacIqZ
M15) obtained from Bio-Rad were used
for mutagenesis, cloning, and plasmid preparation. E. coli SK3981 used to produce thioredoxin and E. coli
A237/pPMR14 used to produce thioredoxin reductase were obtained from A. Holmgren. E. coli MC1009 (
(lacIPOZYA)X74, galE, galK, strA,
(ara-leu)7697, araD139, recA,
srl::Tn10) obtained from Amersham Biosciences,
Inc. was used for expression.
Plasmids-- Plasmid pTB1 (9) containing the gene coding for protein R1 was used in combination with pGP1-2 (40) for overexpression of the mutant R1 proteins using heat induction of the T7 RNA polymerase system.
Oligonucleotide-directed Mutagenesis-- Construction of the site-directed mutations N437S, N437A, N437D, and N437Q of pTB1 was done with the uracil-DNA method described by Kunkel et al. (41, 42) using wild-type pTB1 as a template. The Muta-Gene Phagemid in vitro Mutagenesis kit from Bio-Rad was used.
To verify the absence of secondary mutations, a 532-base pair SfuI/MluI fragment of the mutants N437S, N437A, and N437D was sequenced and cloned into wild-type pTB1 plasmid. The complete R1 gene was sequenced in pTB1(N437Q). In this mutant, a silent secondary mutation at position Pro-701 was found.
Expression of Mutant R1 Proteins--
E. coli
MC1009/pGP1-2 containing one of the mutant pTB1 plasmids N437S, N437A,
N437D, and N437Q was grown in five flasks with each 1 liter of LB
medium (total 5 liters medium) with kanamycin (50 µg/ml) and
carbenicillin (50 µg/ml). The cultures were grown at 30 °C and
shaken vigorously (260 rpm). When the cultures had grown in logarithmic
phase for at least three generations and reached an absorbance
of A640 = 0.5-0.7, the temperature was raised to 42 °C to induce overproduction of the cloned R1 gene. When the
cultures reached stationary phase at A640 = 2.1-2.4 after ~4 h of induction, the cells were quickly
chilled on ice and harvested by centrifugation. Pellets were frozen on
dry ice and stored at
80 °C.
Protein Purification-- Frozen cells were disintegrated in a BIOX X-press and resuspended in extraction buffer containing 50 mM Tris-Cl, pH 7.6, 10 mM MgCl2, 20% glycerol, 2 mM DTT, and 10 µM phenylmethylsulfonyl fluoride. Purification was done as described by Sjöberg et al. (43) with the modifications described by Larsson et al. (44). The final purification step was ion-exchange chromatography on the fast protein liquid chromatography system from Amersham Biosciences, Inc. with a MonoQ column or the Consep LC100 system from Millipore with a Memsep 1500 column (32). Purification was monitored with SDS-PAGE with Coomassie Blue staining. The last chromatography step proved necessary to avoid unspecific precipitation of the R1 preparations during EPR experiments.
Protein Determination--
Protein concentrations
were determined using the absorbance at 280 nm minus the absorbance at
310 nm (A280-310). The stained SDS-PAGE
gels were scanned in a Molecular Dynamics Inc. computing laser
densitometer to calculate the purity of the protein preparations. The
extinction coefficients (
280-310) used were 180,000 M
1 cm
1 for protein R1 and
120,000 M
1 cm
1 for protein R2.
Assay of Enzyme Activity-- The activity of ribonucleotide reductase was determined by the [3H]CDP assay or the spectrophotometric assay measuring NADPH oxidation at 340 nm (26, 32), using 0.06-0.1 µM R1 and 1 µM R2 to give at least 10 × excess of R2 over R1. Reaction conditions were 0.5 mM CDP, 1.5 mM ATP, 13 µM thioredoxin, 0.5 µM thioredoxin reductase, 0.4 mM NADPH, 11 mM Mg(CH3COO)2, and 33 mM HEPES, pH 7.6; in the [3H]CDP assay, 10 mM DTT was used as the reductant instead of thioredoxin reductase and NADPH. There was no difference in RNR-specific activity depending on the reductant used. A CDP concentration of 2.0 mM in combination with 15 mM Mg(CH3COO)2 was also used with other reaction conditions as above.
For measurements of protein R1 activity in crude extracts, MC1009 or MC1009/pGP1-2/pTB1 were grown, harvested, and disintegrated as described above. Extracts were prepared as described above and assayed after desalting of the ammonium sulfate precipitation (43). Protein concentration was determined by the Bradford method (45), and assays were performed as described above, i.e. in the presence of an excess of protein R2.
One unit of ribonucleotide reductase activity is defined as the amount of protein R1 that catalyzes the formation of 1 nmol of product/min in the presence of excess R2 protein at 25 °C. Specific activity is expressed in units/milligrams of protein R1.
Time-dependent UV-visible Absorption
Spectroscopy--
The time dependence of tyrosyl radical decay
was monitored in a PerkinElmer Life Sciences
2 scanning
spectrophotometer. The enzyme mixture contained 10 µM R1
protein (mutant or wild type), 7.5 µM wild-type R2
(1.0-1.2 Tyr·/R2), 0.25 mM dTTP, 15 mM
Mg(CH3COO)2, 5 mM DTT in 50 mM Tris-Cl, pH 7.6. The reaction was started by the
addition of an aliquot of CDP or CzDP to a final concentration of 2 mM or 1.7 mM, respectively, and several
300-450-nm spectra were recorded at 25 °C for 1-3 h with a speed
of 480 nm/min.
The tyrosyl radical decay at 410 nm was calculated with dropline
correction between 405-420 nm (i.e. the tyrosyl radical
absorption at 410 nm corrected to the line defined by the absorption
values at 405 and 420 nm) using the extinction coefficient
(
410) 2,110 M
1
cm
1 (46). Tyrosyl radical decay curves were analyzed by
curve fitting to linear, single exponential, or double exponential
decay as specified in the footnotes to the tables.
Time-dependent formation of a 317-nm chromophore was monitored as above but in the absence of DTT. In these experiments, all solutions were deoxygenated by flushing with argon prior to mixing. R1 protein solutions were prereduced with 10 mM DTT for 5 min at room temperature and desalted on NAP-5 columns equilibrated with argon-flushed buffer (50 mM Tris-HCl, pH 7.6, 15 mM Mg(CH3COO)2). At the end of incubations, all samples were analyzed by SDS-PAGE for the potential truncation of protein R1.
Stopped-flow experiments were performed in an SX.18MV BioSequential stopped-flow ASVD spectrofluorimeter from Applied Photophysics with 55 µl of each reactant per shot. Syringe A contained 30 µM wild-type R2 (1.0-1.2 Tyr·/R2) and 40 µM mutant R1 protein, and syringe B contained 4 mM CDP. Both syringes contained 0.25 mM dTTP, 15 mM Mg(CH3COO)2 in 50 mM Tris, pH 7.6, at 25 °C. Traces were monitored at 405, 410, 420, and 450 nm and evaluated using the SX18MV software.
EPR Samples and Measurements--
The reactions were performed
at 25 °C by rapidly mixing equal volumes of the protein solution,
150 µM R1, 100 µM R2 in 50 mM
Tris-Cl, pH 7.6, 15 mM Mg(CH3COO)2,
0.2-0.25 mM dTTP, 5 mM DTT, and the substrate
solution of 3.34 mM CDP in the same buffer. Samples
containing protein solution and buffer without substrate were used to
detect the initial amount of tyrosyl radical and as a control of
unspecific tyrosyl radical decay. Reactions were started by adding the
substrate solution to the protein solution and were stopped by freezing
in N-pentane cooled with liquid nitrogen to
110 °C.
Incubation times of 2 s or longer were obtained by this method.
EPR spectra at 9 GHz measured at 77 K were recorded on a Bruker ESP 300 spectrometer using a cold finger Dewar flask for liquid nitrogen. Spin
quantitation was obtained with a Cu2+-EDTA sample (1 mM Cu2+, 10 mM EDTA) and a
secondary standard of active wild-type E. coli R2 protein
(0.98 mM tyrosyl radical) by comparing the double integrals. Subtractions were performed using the ESP 300 software.
| |
RESULTS |
|---|
|
|
|---|
Yield and Purity of Mutant R1 Proteins-- All the mutant R1 proteins behaved as wild-type R1 throughout the protein purification procedure, and the final yields were typically 5-18 mg of R1 protein (90-95% pure)/g of wet cells, similar to earlier reported yields of active site mutants (32). The estimated amount of contaminating wild-type protein was about 1%, calculated from the amount of chromosomally encoded wild-type protein in crude extracts (Table I) (47). The overall yield throughout the purification procedure was 30-50%.
|
Enzyme Activity of Mutant R1 Proteins as Compared with Wild-type R1-- An initial characterization of the mutant R1 proteins measured their specific enzyme activities (using CDP as a substrate and ATP as effector). Compared with wild-type R1 enzyme activity, all the mutants had activities of ~1-2% of the wild-type activity (Table I). A low activity in a mutant protein may imply that it has some intrinsic activity per se. However, the low activities measured in the mutant proteins of this study are plausibly explained by a low amount of contaminating chromosomally encoded wild-type R1 protein (cf. Table I) (47) and an absence of intrinsic activity in the mutant proteins. The presumed absence of activity encouraged us to further characterize the reactions of the mutant proteins with the kcat inhibitor CzDP to monitor 3'-H abstraction from the substrate.
The Mutations at Position Asn-437 Can Promote Tyrosyl Radical Decay
in Presence of CzDP--
The 2'-azido-substituted substrate analogue
CzDP is a mechanism-based inhibitor (Scheme
2) that mediates a half turnover reaction characterized by tyrosyl radical decay, 3'-H abstraction, and subsequent formation of a substrate-derived radical coupled to Cys-225
(step 10 in Scheme 2) (27, 48, 49). Our aim was to use the
CzDP reaction to distinguish between low intrinsic activity in a mutant
protein and contaminating chromosomally encoded wild-type protein in
the mutant protein preparation.
|
Time-dependent UV-visible absorption spectroscopy was used
to follow the decay of the 410-nm band in an incubation mixture containing CzDP. The time-dependent loss of the tyrosyl
radical in N437Q is shown in Fig. 1
together with two controls: the wild-type reaction with a fast tyrosyl
radical decay and the catalytically inactive mutant E441A (32) with no
tyrosyl radical decay. It is evident that the N437Q protein promotes a
fast tyrosyl radical decay (Fig. 1) despite the fact that it has
virtually no enzyme activity. Curve fitting of two independent
exponential decay reactions to the data gave estimates of the rate
constants of the tyrosyl radical decay. The N437Q mutant behaves as
wild-type R1 with a fast decay of more than half of the starting
concentration of tyrosyl radical in R2 (Table
II). The other Asn-437 mutants were comparable with N437Q (Table II and Fig.
2A). These results show that
all Asn-437 mutants can promote mechanism-based radical transfer and
3'-H abstraction.
|
|
|
All Mutations at Asn-437, Except N437Q, Have a Suicidal
Phenotype--
The unexpected CzDP results prompted us to perform
similar studies with the physiological substrate CDP. In the two
controls (wild-type R1 and E441A), the tyrosyl radical was essentially stable over the duration of the experiment (Fig. 2B),
showing that neither a fully functional radical transfer (as in
wild-type R1) nor a complete lack of radical transfer (as in the E441A) gives rise to tyrosyl radical decay. The N437Q protein shows no tyrosyl
radical decay (Figs. 2B and
3), in agreement with its very low
enzymatic activity. In contrast, the other three mutant proteins
engineered at the Asn-437 position promoted a substantial tyrosyl
radical decay in the CDP reactions (Figs. 2B and 3 and Table
III), suggesting that they have a
suicidal phenotype. Control incubations of mutant R1 proteins with R2
and effector nucleotide but in the absence of substrate showed no decay
of the tyrosyl radical during 50 min.
|
|
Based on these results, we attempted to trap radical intermediates during the suicidal reactions by performing freeze-quench EPR experiments with the N437D/S proteins. Although the tyrosyl radical decay was readily monitored in these experiments, no other radical intermediates were observed during a time span of 2 s to 30 min.
A Furanone Adduct Is Formed in the N437D Suicidal
Reaction--
Suicidal reactions with E. coli R1 protein
often involve the formation of furanone adducts with typical
chromophores in the 320-nm region if performed in the absence of DTT
(50). We therefore repeated the UV-visible experiments with N437Q/A/S/D
and CDP in anaerobic buffers devoid of chemical reductants to avoid
trapping of the furanone by DTT. The tyrosyl radical decay rates in
N437A/S/D were similar to those shown in Table III for the
DTT-containing incubations. No tyrosyl radical decay occurred in the
N437Q incubations. A chromophore characteristic of furanone and
centered at 317 nm formed in the reactions with N437D (Fig.
4) but not in the N437Q/A/S reactions.
Using molar extinction coefficients of 20,000-24,800 M
1 cm
1 (50) for the furanone
adduct, the concentration of furanone adduct was 17-20
µM after a 40-min incubation of 10 µM N437D
with excess CDP and protein R2, indicating that more than 85% of the active sites in the mutant R1 protein had a covalently bound furanone species.
|
| |
DISCUSSION |
|---|
|
|
|---|
In this study, we have assessed the importance of Asn-437, a conserved residue in the active site region in protein R1 of E. coli RNR. Previous studies have identified the individual roles of the conserved active site residues Cys-225, Cys-439, Cys-462 (9, 12), and Glu-441 (32). Our first observation is that Asn-437 is a catalytically essential residue because four different substitutions (N437Q/A/S/D) result in catalytically inert mutant proteins. However, all mutant proteins promoted tyrosyl radical decay from protein R2 by the kcat inhibitor CzDP. The suicidal CzDP reaction is diagnostic for 3'-H abstraction (Scheme 2), the first substrate-related step in the reaction sequence. The most enlightening results were that three of the mutant enzymes (N437A/S/D) also underwent rapid protein R2 tyrosyl radical decay in the presence of the natural substrate CDP. The subsequent formation of a 317-nm furanone adduct in the N437D mutant is diagnostic of substrate decomposition.
Model studies (33, 51) and theoretical calculations (16, 30) suggest that the driving force in the first part of the RNR mechanism is the elimination of the protonated 2'-OH group as water (Scheme 1). Subsequent one-electron reduction generates the 3'-keto intermediate (step 4 in Scheme 1), the most stable reaction intermediate in the mechanism. It has been suggested that the 3'-keto intermediate requires protonation at the keto group before the second electron reduction can occur. Reduction of the 3'-keto intermediate is therefore believed to be the rate-limiting step in single turnover conditions.
X-ray crystallography showed that Asn-437 and Glu-441 participate in a hydrogen-bonded network that connects the 2'-OH and 3'-OH groups of the substrate (8). The theoretical calculations suggest that Asn-437 and Glu-441 may in fact mediate the protonation of the 2'-OH. Effectively, this would imply that the 3'-OH, and not Cys-225 as suggested by Stubbe and co-workers (11), protonates the 2'-OH (16, 30). It has also been suggested by Eriksson et al. (8) that the hydrogen-bonded Asn-437 and Glu-441 may participate in the second one-electron reduction of the substrate. Recent results with the suicidal mutant E441Q corroborates that protonation of the 3'-keto intermediate may in fact be a critical step (30, 34, 35). Of the four different substitutions in the 437 position, all except N437A are capable of hydrogen bond formation. However, depending upon the restraints and/or the chemical nature of the hydrogen bonds, we would expect the mutations to be more or less disturbed in the water elimination step and/or the protonation and reduction of the 3'-keto intermediate.
An inactive mutant R1 protein, which can promote 3'-H abstraction, may follow at least three different reaction sequences with different end results: (i) it may not allow the water elimination, resulting in a non-suicidal reaction with CDP, as the radical transfer reaction is strongly biased toward Tyr-122·; (ii) it may promote the water elimination but then utilize Cys-439 for the subsequent one-electron reduction, resulting in a reactive nucleotide intermediate that eventually decomposes (52) and more or less prominent tyrosyl radical decay, depending on the efficiency with which Cys-439 reacts (49); and (iii) it may promote the water elimination followed by the one-electron reduction by Cys-225 but deviate at step 4 in Scheme 1, leading to a rapid stoichiometric tyrosyl radical decay and subsequent substrate decomposition.
The mutant N437Q may plausibly follow the first reaction sequence. We consider it less likely that it follows the second reaction sequence because no tyrosyl radical decay was observed and no diagnostic 320-nm chromophore was seen in anaerobic incubations with N437Q. Mutants N437A, N437S, and N437D conceivably allow water elimination and are likely to react according to the third reaction sequence, at least partially. A defective reduction of the 3'-keto intermediate would give rise to furanone-like reactions (32, 34) and show the diagnostic formation of the 320-nm band (52). Such a chromophore was only observed in the N437D mutant. The defective reactions in N437A/S may distribute between the second and third reaction sequence and give rise to several different end products in respectively lower concentrations. Another diagnostic test for transient non-physiological radicals formed subsequently to the water elimination step is mechanism-based truncation of the R1 protein. The suicidal mutant protein C225S plausibly forms a transient Ser-225 radical that results in truncation of the mutant protein at that particular position (53). Neither mutant protein used in this study contained any truncated R1 (or R2) protein when assayed by SDS-PAGE after a 1-3-h incubation in the reaction mixture.
Collectively, our results demonstrate that Asn-437 is essential for
catalysis in class I RNRs, plausibly by participating in the
protonation and reduction of the 3'-keto intermediate (cf. Scheme 1). It seems less likely that Asn-437 is critical for the water
elimination step, as suggested previously (8, 16, 30). However, a role
for Asn-437 in the first one-electron reduction of the 2'-position of
the substrate cannot be excluded.
| |
FOOTNOTES |
|---|
* This work was supported by grants from the Swedish Cancer Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Present address: Dept. of Zoological Cell Biology, the Wenner-Gren
Institute, Stockholm University, SE-10691 Stockholm, Sweden.
§ To whom correspondence should be addressed: Tel.: 46-8-164150; Fax: 46-8-152350; E-mail: Britt-Marie.Sjoberg@molbio.su.se.
Published, JBC Papers in Press, December 3, 2001, DOI 10.1074/jbc.M106538200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: RNR, ribonucleotide reductase; CzDP, 2'-azido-2'-deoxy-CDP; CzTP, 2'-azido-2'-deoxy-CTP; DTT, dithiothreitol.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Sjöberg, B.-M. (1997) Struct. Bonding 88, 139-173 |
| 2. | Jordan, A., and Reichard, P. (1998) Annu. Rev. Biochem. 67, 71-98[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Logan, D. T.,
Andersson, J.,
Sjöberg, B.-M.,
and Nordlund, P.
(1999)
Science
283,
1499-1504 |
| 4. | Licht, S., Gerfen, G. J., and Stubbe, J. A. (1996) Science 271, 477-481[Abstract] |
| 5. | Eklund, H., and Fontecave, M. (1999) Structure Fold Des 7, R257-R262[Medline] [Order article via Infotrieve] |
| 6. | Nordlund, P., Sjöberg, B.-M., and Eklund, H. (1990) Nature 345, 593-598[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Uhlin, U., and Eklund, H. (1994) Nature 370, 533-539[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Eriksson, M., Uhlin, U., Ramaswamy, S., Ekberg, M., Regnström, K., Sjöberg, B.-M., and Eklund, H. (1997) Structure 5, 1077-1092[Medline] [Order article via Infotrieve] |
| 9. |
Åberg, A.,
Hahne, S.,
Karlsson, M.,
Larsson, A.,
Ormö, M.,
Åhgren, A.,
and Sjöberg, B.-M.
(1989)
J. Biol. Chem.
264,
12249-12252 |
| 10. | Mao, S. S., Yu, G. X., Chalfoun, D., and Stubbe, J. (1992) Biochemistry 31, 9752-9759[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Mao, S. S., Holler, T. P., Bollinger, J. J., Yu, G. X., Johnston, M. I., and Stubbe, J. (1992) Biochemistry 31, 9744-9751[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Mao, S. S., Holler, T. P., Yu, G. X., Bollinger, J. M., Booker, S., Johnston, M. I., and Stubbe, J. (1992) Biochemistry 31, 9733-9743[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Larsson, Å., and Sjöberg, B.-M. (1986) EMBO J. 5, 2037-2040[Medline] [Order article via Infotrieve] |
| 14. |
Petersson, L.,
Gräslund, A.,
Ehrenberg, A.,
Sjöberg, B.-M.,
and Reichard, P.
(1980)
J. Biol. Chem.
255,
6706-6712 |
| 15. | Nordlund, P., and Eklund, H. (1993) J. Mol. Biol. 232, 123-164[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Siegbahn, P. E. M. (1998) J. Am. Chem. Soc. 120, 8417-8429[CrossRef] |
| 17. |
Schmidt, P. P.,
Rova, U.,
Katterle, B.,
Thelander, L.,
and Gräslund, A.
(1998)
J. Biol. Chem.
273,
21463-21472 |
| 18. | Climent, I., Sjöberg, B.-M., and Huang, C. Y. (1992) Biochemistry 31, 4801-4807[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Rova, U., Goodtzova, K., Ingemarson, R., Behravan, G., Gräslund, A., and Thelander, L. (1995) Biochemistry 34, 4267-4275[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Persson, B. O., Karlsson, M., Climent, I., Ling, J. S., Sanders Loehr, J., Sahlin, M., and Sjöberg, B.-M. (1996) J. Biol. Inorg. Chem. 1, 247-256[CrossRef] |
| 21. |
Ekberg, M.,
Sahlin, M.,
Eriksson, M.,
and Sjöberg, B.-M.
(1996)
J. Biol. Chem.
271,
20655-20659 |
| 22. |
Ekberg, M.,
Pötsch, S.,
Sandin, E.,
Thunnissen, M.,
Nordlund, P.,
Sahlin, M.,
and Sjöberg, B. M.
(1998)
J. Biol. Chem.
273,
21003-21008 |
| 23. |
Rova, U.,
Adrait, A.,
Pötsch, S.,
Gräslund, A.,
and Thelander, L.
(1999)
J. Biol. Chem.
274,
23746-23751 |
| 24. |
Stubbe, J.,
and Ackles, D.
(1980)
J. Biol. Chem.
255,
8027-8030 |
| 25. |
Stubbe, J.,
Ator, M.,
and Krenitsky, T.
(1983)
J. Biol. Chem.
258,
1625-1631 |
| 26. |
Thelander, L.,
and Larsson, B.
(1976)
J. Biol. Chem.
251,
1398-1405 |
| 27. |
Sjöberg, B.-M.,
Gräslund, A.,
and Eckstein, F.
(1983)
J. Biol. Chem.
258,
8060-8067 |
| 28. | Ator, M. A., and Stubbe, J. (1985) Biochemistry 24, 7214-7221[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | van der Donk, W. A., Stubbe, J., Gerfen, G. J., Bellew, B. F., and Griffin, R. G. (1995) J. Am. Chem. Soc. 117, 8908-8916[CrossRef] |
| 30. | Himo, F., and Siegbahn, P. E. M. (2000) J. Phys. Chem. B 104, 7502-7509[CrossRef] |
| 31. | Stubbe, J. A., and van der Donk, W. A. (1995) Chem. Biol. 2, 793-801[CrossRef][Medline] [Order article via Infotrieve] |
| 32. |
Persson, A. L.,
Eriksson, M.,
Katterle, B.,
Pötsch, S.,
Sahlin, M.,
and Sjöberg, B.-M.
(1997)
J. Biol. Chem.
272,
31533-31541 |
| 33. | Lenz, R., and Giese, B. (1997) J. Am. Chem. Soc. 119, 2784-2794[CrossRef] |
| 34. |
Persson, A. L.,
Sahlin, M.,
and Sjöberg, B.-M.
(1998)
J. Biol. Chem.
273,
31016-31020 |
| 35. |
Lawrence, C. C.,
Bennati, M.,
Obias, H. V.,
Bar, G.,
Griffin, R. G.,
and Stubbe, J.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
8979-8984 |
| 36. | Uhlin, U., and Eklund, H. (1996) J. Mol. Biol. 262, 358-369[CrossRef][Medline] [Order article via Infotrieve] |
| 37. |
Lunn, C. A.,
Kathju, S.,
Wallace, B. J.,
Kushner, S. R.,
and Pigiet, V.
(1984)
J. Biol. Chem.
259,
10469-10474 |
| 38. |
Russel, M.,
and Model, P.
(1985)
J. Bacteriol.
163,
238-242 |
| 39. | Wehrli, W. E., Verheyden, D., and Moffat, J. G. (1965) J. Am. Chem. Soc. 87, 2265-2277[CrossRef][Medline] [Order article via Infotrieve] |
| 40. |
Tabor, S.,
and Richardson, C. C.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
1074-1078 |
| 41. |
Kunkel, T. A.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
488-492 |
| 42. | Kunkel, T. A., Roberts, J. D., and Zakour, R. A. (1987) Methods Enzymol. 154, 367-382[Medline] [Order article via Infotrieve] |
| 43. |
Sjöberg, B.-M.,
Hahne, S.,
Karlsson, M.,
Jörnvall, H.,
Göransson, M.,
and Uhlin, B. E.
(1986)
J. Biol. Chem.
261,
5658-5662 |
| 44. |
Larsson, Å.,
Karlsson, M.,
Sahlin, M.,
and Sjöberg, B.-M.
(1988)
J. Biol. Chem.
263,
17780-17784 |
| 45. | Bradford, M. M. (1976) Anal. Biochem. 72, 248-254[CrossRef][Medline] [Order article via Infotrieve] |
| 46. | Bollinger, J. M., Tong, W. H., Ravi, N., Huynh, B. H., Edmondson, D. E., and Stubbe, J. (1994) J. Am. Chem. Soc. 116, 8015-8023[CrossRef] |
| 47. |
Eriksson, S.,
Sjöberg, B.-M.,
and Hahne, S.
(1977)
J. Biol. Chem.
252,
6132-6138 |
| 48. | Salowe, S. P., Ator, M. A., and Stubbe, J. (1987) Biochemistry 26, 3408-3416[CrossRef][Medline] [Order article via Infotrieve] |
| 49. | van der Donk, W. A., Yu, G. X., Silva, D. J., and Stubbe, J. (1996) Biochemistry 35, 8381-8391[CrossRef][Medline] [Order article via Infotrieve] |
| 50. | Stubbe, J. (1990) Adv. Enzymol. Relat. Areas Mol. Biol. 63, 349-419[Medline] [Order article via Infotrieve] |
| 51. | Robins, M. J., Guo, Z. Q., Samano, M. C., and Wnuk, S. F. (1999) J. Am. Chem. Soc. 121, 1425-1433[CrossRef] |
| 52. | Harris, G., Ator, M., and Stubbe, J. (1984) Biochemistry 23, 5214-5225[CrossRef][Medline] [Order article via Infotrieve] |
| 53. | van der Donk, W. A., Zeng, C. H., Biemann, K., Stubbe, J., Hanlon, A., and Kyte, J. (1996) Biochemistry 35, 10058-10067[Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
N. M. F. S. A. Cerqueira, P. A. Fernandes, L. A. Eriksson, and M. J. Ramos Dehydration of Ribonucleotides Catalyzed by Ribonucleotide Reductase: The Role of the Enzyme Biophys. J., March 15, 2006; 90(6): 2109 - 2119. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals |